BACKGROUND AND OBJECTIVES: With the advent of fetal screening ultrasonography, the detection of congenital anomalies of the kidney and urinary tract (CAKUT) in utero has permitted early management of these conditions. This study aims to describe the clinical course of a large cohort of patients with prenatally detected nephrouropathies. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective cohort study, 822 patients were prenatally diagnosed with CAKUT and systematically followed up at a tertiary Renal Unit for a median time of 43 months. Variables included in the analysis were sex, laterality, fetal ultrasonography (isolated versus associated hydronephrosis), and presence/absence of nephrouropathies. The events of interest were urinary tract infection, surgical interventions, hypertension, CKD, and death. Survival analyses were performed to evaluate time until occurrence of the events of interest. RESULTS: Urinary tract infection occurred in 245 (29.8%) children, with higher risk in females (hazard ratio=1.30, 95% confidence interval=1.02-1.70, P=0.05); 22 patients (2.7%) had hypertension, and 49 (6%) patients developed CKD. The risk of CKD was greater in patients with associated hydronephrosis (hazard ratio=5.20, 95% confidence interval=2.90-9.30, P<0.001). Twelve patients (1.5%) died during follow-up. Death was significantly associated with being born during the first period of the study (hazard ratio=6.00, 95% confidence interval=1.60-22.50, P<0.001), associated hydronephrosis (hazard ratio=9.30, 95% confidence interval=2.90-29.30, P<0.001), and CKD (hazard ratio=170.00, 95% confidence interval=41.00-228.00, P<0.001). CONCLUSIONS: In our series, the clinical course of prenatally detected CAKUT was heterogeneous, and those infants with associated hydronephrosis at baseline were identified as a high-risk subgroup.
BACKGROUND AND OBJECTIVES: With the advent of fetal screening ultrasonography, the detection of congenital anomalies of the kidney and urinary tract (CAKUT) in utero has permitted early management of these conditions. This study aims to describe the clinical course of a large cohort of patients with prenatally detected nephrouropathies. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective cohort study, 822 patients were prenatally diagnosed with CAKUT and systematically followed up at a tertiary Renal Unit for a median time of 43 months. Variables included in the analysis were sex, laterality, fetal ultrasonography (isolated versus associated hydronephrosis), and presence/absence of nephrouropathies. The events of interest were urinary tract infection, surgical interventions, hypertension, CKD, and death. Survival analyses were performed to evaluate time until occurrence of the events of interest. RESULTS:Urinary tract infection occurred in 245 (29.8%) children, with higher risk in females (hazard ratio=1.30, 95% confidence interval=1.02-1.70, P=0.05); 22 patients (2.7%) had hypertension, and 49 (6%) patients developed CKD. The risk of CKD was greater in patients with associated hydronephrosis (hazard ratio=5.20, 95% confidence interval=2.90-9.30, P<0.001). Twelve patients (1.5%) died during follow-up. Death was significantly associated with being born during the first period of the study (hazard ratio=6.00, 95% confidence interval=1.60-22.50, P<0.001), associated hydronephrosis (hazard ratio=9.30, 95% confidence interval=2.90-29.30, P<0.001), and CKD (hazard ratio=170.00, 95% confidence interval=41.00-228.00, P<0.001). CONCLUSIONS: In our series, the clinical course of prenatally detected CAKUT was heterogeneous, and those infants with associated hydronephrosis at baseline were identified as a high-risk subgroup.
Authors: Cristina M Bouissou Soares; José Silvério S Diniz; Eleonora M Lima; Jose M Penido Silva; Gilce R Oliveira; Monica R Canhestro; Enrico A Colosimo; Ana Cristina Simoes e Silva; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2008-06-17 Impact factor: 3.714
Authors: Simone Sanna-Cherchi; Pietro Ravani; Valentina Corbani; Stefano Parodi; Riccardo Haupt; Giorgio Piaggio; Maria L Degli Innocenti; Danio Somenzi; Antonella Trivelli; Gianluca Caridi; Claudia Izzi; Francesco Scolari; Girolamo Mattioli; Landino Allegri; Gian Marco Ghiggeri Journal: Kidney Int Date: 2009-06-17 Impact factor: 10.612
Authors: Graziela M Coelho; Maria Candida F Bouzada; Gilberto S Lemos; Alamanda K Pereira; Bernado P Lima; Eduardo A Oliveira Journal: J Urol Date: 2007-11-14 Impact factor: 7.450
Authors: Cristina M Soares; José Silvério S Diniz; Eleonora M Lima; Gilce R Oliveira; Monica R Canhestro; Enrico A Colosimo; Ana Cristina Simoes e Silva; Eduardo A Oliveira Journal: Nephrol Dial Transplant Date: 2008-10-07 Impact factor: 5.992
Authors: Graziela M Coelho; Maria Candida F Bouzada; Alamanda K Pereira; Bruno F Figueiredo; Maria Rafaela S Leite; Danielly S Oliveira; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2007-07-26 Impact factor: 3.714
Authors: Mariana A Vasconcelos; Ana Cristina Simões E Silva; Izabella R Gomes; Rafaela A Carvalho; Sergio V Pinheiro; Enrico A Colosimo; Peter Yorgin; Robert H Mak; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2018-09-08 Impact factor: 3.714
Authors: Débora Marques de Miranda; Augusto César Soares Dos Santos Júnior; Geisilaine Soares Dos Reis; Izabella Silva Freitas; Thiago Guimarães Rosa Carvalho; Luiz Armando Cunha de Marco; Eduardo Araújo Oliveira; Ana Cristina Simões E Silva Journal: Mol Diagn Ther Date: 2014-08 Impact factor: 4.074
Authors: Andrew L Schwaderer; Huanyu Wang; SungHwan Kim; Jennifer M Kline; Dong Liang; Pat D Brophy; Kirk M McHugh; George C Tseng; Vijay Saxena; Evan Barr-Beare; Keith R Pierce; Nader Shaikh; J Robert Manak; Daniel M Cohen; Brian Becknell; John D Spencer; Peter B Baker; Chack-Yung Yu; David S Hains Journal: J Am Soc Nephrol Date: 2016-03-03 Impact factor: 10.121
Authors: Isabel G Quirino; Cristiane S Dias; Mariana A Vasconcelos; Isabel V Poggiali; Kerlane C Gouvea; Alamanda K Pereira; Gabriela P Paulinelli; Amanda R Moura; Raquel S Ferreira; Enrico A Colosimo; Ana Cristina Simões E Silva; Eduardo A Oliveira Journal: Pediatr Nephrol Date: 2014-06-19 Impact factor: 3.714